Related Experiment Video

Updated: Jul 11, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

Hypothesis: myostatin is a mediator of cardiac cachexia

Michel R Hoenig

    International Journal of Cardiology
    |October 2, 2007
    PubMed

    Insights

    Myostatin, a regulator of muscle mass, may play a role in heart failure complications. This includes cardiac cachexia, insulin resistance, and osteoporosis, offering new avenues for research.

    Area of Science:

    • Biochemistry
    • Physiology
    • Cardiology

    Background:

    • Myostatin is identified as a key negative regulator of skeletal muscle mass.
    • Advanced heart failure is associated with significant comorbidities including cardiac cachexia, insulin resistance, and osteoporosis.

    Discussion:

    • This paper explores the potential involvement of the myostatin system in the pathophysiology of these advanced heart failure complications.
    • Investigating myostatin's role could elucidate mechanisms linking muscle wasting, metabolic dysfunction, and bone density loss in heart failure patients.

    Key Insights:

    • Hypothesizes a functional role for myostatin in cardiac cachexia.
    • Proposes myostatin's involvement in insulin resistance associated with heart failure.
    • Suggests a link between myostatin and osteoporosis in advanced heart failure.

    Outlook:

    • Further research is warranted to validate the hypothesized role of myostatin in these conditions.
    • Understanding myostatin's contribution may lead to novel therapeutic strategies for managing heart failure comorbidities.
    • This hypothesis opens new research directions in the study of muscle wasting and metabolic disturbances in cardiovascular disease.

    Related Concept Videos

    Satellite Stem Cells and Muscular Dystrophy01:21

    Satellite Stem Cells and Muscular Dystrophy

    Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    Formation of Muscle Fibers from Myoblasts01:13

    Formation of Muscle Fibers from Myoblasts

    De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
    Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
    Cross-bridge Cycle01:26

    Cross-bridge Cycle

    As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
    Cellular Adaptation II: Hypertrophy01:26

    Cellular Adaptation II: Hypertrophy

    Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...